Randomized Controlled Trial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2024; 12(2): 314-321
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.314
Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease
Ting Gao, Jin-Lan Luo, Pan Guo, Xi-Wen Hu, Xiao-Yan Wei, Yan Hu
Ting Gao, Division of Cardiovascular First Ward, Department of Internal Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, Hubei Province, China
Jin-Lan Luo, Department of Cardiovascular Medicine, Wuhan Wuchang Hospital, Wuhan 430063, Hubei Province, China
Pan Guo, Xi-Wen Hu, Xiao-Yan Wei, Cardiovascular Clinical Medical Center, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, Hubei Province, China
Yan Hu, Department of Second Thoracic Surgery, Hubei Cancer Hospital, Wuhan 430079, Hubei Province, China
Co-first authors: Ting Gao and Jin-Lan Luo.
Author contributions: Gao T and Luo JN designed the research; Guo P, Hu XW, Wei XY and Hu Y contributed new reagents/analytic tools; Guo P, Hu XW, Wei XY and Hu Y analyzed the data; Gao T and Luo JN wrote the paper. All authors were involved in the critical review of the results and have contributed to, read, and approved the final manuscript. Gao T and Luo JN contributed equally to this work as co-first authors equally to this work. The reasons for naming Gao T and Luo JN as co-first authors are threefold. First, the research was a collaborative effort, and the designation accurately reflects the distribution of responsibilities and burdens. This ensures effective communication and post-submission management, enhancing the paper's quality and reliability. Second, the team encompassed diverse expertise and skills, and the designation reflects this diversity, promoting comprehensive and in-depth examination, enriching readers' understanding. Third, Gao and Luo contributed equally throughout the research process. Their designation acknowledges equal contribution and teamwork spirit. We believe naming them co-first authors accurately reflects our team's collaborative spirit, equal contributions, and diversity.
Institutional review board statement: The study was reviewed and approved by the Hubei Cancer Hospital Institutional Review Board.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors declare no potential conflicting interests related to this paper.
Data sharing statement: Data generated from this investigation are available upon reasonable quest from the corresponding author.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yan Hu, Nurse, Department of Second Thoracic Surgery, Hubei Cancer Hospital, No. 116 Zhuodaoquan South Road, Hongshan District, Wuhan 430079, Hubei Province, China. yanyan663311@163.com
Received: November 3, 2023
Peer-review started: November 3, 2023
First decision: November 16, 2023
Revised: December 6, 2023
Accepted: December 28, 2023
Article in press: December 28, 2023
Published online: January 16, 2024
Processing time: 69 Days and 1.9 Hours
ARTICLE HIGHLIGHTS
Research background

Lung cancer and coronary heart disease (CHD) have become the major diseases worldwide and often occur simultaneously in the same patient. This comorbidity poses great challenges for treatment, especially for those patients who underwent percutaneous coronary intervention (PCI). Therefore, it has important theoretical and practical implications to explore how to improve the prognosis and quality of life of such patients through continuous care.

Research motivation

The concerns of the complex physical and mental problems that patients face during the course of their disease, and the potential importance of continuous care in clinical practice in improving patient quality of life.

Research objectives

This study aims to explore the impact of continuous care in patients with lung cancer and CHD undergoing PCI.

Research methods

Continuous care was provided in the intervention group and the usual care in the control group.

Research results

There were significant differences between the groups in left ventricular ejection fraction, 6-min walking test, oxygen uptake, quality of life, and medication adherence (P < 0.05). The improvement was more significant in the intervention group compared to the control group. Higher in the intervention group than the control group, and the difference was statistically significant (P < 0.05).

Research conclusions

After PCI, patients with CHD with lung disease may benefit from continuity of care, including cardiac and pulmonary function, medication adherence, and quality of life.

Research perspectives

By exploring in depth the impact of continuous care in patients with PCI lung cancer with CHD, we expect to provide more effective treatment strategies and care options for clinicians and caregivers, which thus improve patient outcomes and quality of life.